Popular Articles

Mapping Gene Expression With Gene Expression Atlas
Recently, researchers at the European Molecular Biology Laboratory"s European Bioinformatics Institute (EMBL-EBI) launched a new database, the Gene Expression Atlas, which allows scientists to search and compare gene expression data at unprecedented detail and scope. Observing how gene expression varies in different cell types, tissues and under disease conditions can help researchers understand gene function and to develop new drugs and therapies.
generic viagra online
Parkinson's Disease Alters Patient's Ability To Learn From Rewards While Treatment Affects Ability To Learn From Negative Outcomes
A new neuropsychological memory test is helping to uncover how Parkinson"s disease can alter people"s ability to learn about the consequences of the choices they make. The test was developed by Dr. Mark Gluck, professor of neuroscience at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, working with co-researchers at Rutgers, New York University, and in Hungary.
News of the day
MHRA Manufacturing Licence For Avecia Biologics
Avecia Biologics has announced it has received a Manufacturer"s Licence from the UK"s Medicines and Healthcare products Regulatory Agency (MHRA). The Licence authorises commercial manufacturing at the company"s Tees Valley, UK site and comes three months after the company successfully underwent its first FDA Pre-Approval Inspection.
Nutrition

Government Plan Could Sacrifice Equality For Choice In The NHS, UK

In a letter to this week÷´s BMJ, a researcher expresses his concern on how in order to empower NHS patients with choice, the UK government is in danger of sacrificing the principle of equality on which the service was founded. His observations come up at the same time as the Obama administration declared that US healthcare reform is "on track" and would protect the right of patients to choose their doctor. Adam Ali, a Frank Knox Fellow at Harvard University, writes that the US healthcare system is driven by the desire for choice whereas the NHS is driven by the desire for equality. "But, if choice is possible then, by definition, differences exist in the quality of care being provided in the NHS", he writes. He continues by saying that some individuals are receiving a substandard service that an informed patient would not choose. He argues that by permitting patient to choose, inequality will increase since some patients can make more knowledgeable choices than other, in other words wealthy and well educated people. These individuals are more likely to be politically active. As a result, he adds: "promoting choice seems an effective way of scoring political points in the guise of making the NHS fairer". He says in conclusion: "The fairest approach is to foster a system in which choice is not needed, by improving those services which no informed patient would choose". "Choice and equality in health" Adam M Ali, Frank Knox fellow BMJ 2009; 338:b2423 bmj Written by Stephanie Brunner (B.A.) Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):